Pharma channel feed – Endpoints News

Pharma channel feed

EMA recommends revoking authorization of Novartis' sickle cell drug

3 years ago

Janssen reports decline in 2022 net prices as out-of-pocket costs grow

3 years ago

Mirroring Senate counterparts, House committee advances PBM reforms

3 years ago

Gilead adds more patient representation in next phase of HIV med Biktarvy campaign

3 years ago

Merck's $10.8B Prometheus buyout can proceed after antitrust review

3 years ago

Bipartisan lawmakers pressure FDA on common chemotherapies now in shortage

3 years ago

Lilly gears up trio of PhIII trials for its oral GLP-1 amid Novo Nordisk, Pfizer competition

3 years ago

Mirati’s drug sitravatinib flops PhIII in combo with Opdivo for certain lung cancer

3 years ago

Annexon’s GA drug misses on primary goal but win on visual acuity will be focus of planned late-stage trial

3 years ago

Novo Nordisk makes the case it’s more than Wegovy in new corporate ad campaign

3 years ago

District court hands Janssen a win in patent feud with Viatris

3 years ago

Purdue Pharma nabs court approval for $397M sale of consumer health unit

3 years ago

Veeva adds generative AI tool for pharma reps as it rolls out new software platform

3 years ago

CDMO secures a $98M+ NIH contract for production of pediatric HIV-prevention products

3 years ago

New Biden proposal would expose the actual cost of drugs covered by Medicaid

3 years ago

Amgen, Janssen reach settlement on Stelara biosimilar drug, allowing for 2025 launch at latest

3 years ago

Companies ask FDA for regulation, improvement of data collection from digital health devices

3 years ago

FDA warns Sure-BioChem over quality and data issues

3 years ago

Walgreens asks federal court to toss Humana's $642M payout in drug pricing case

3 years ago

House committee takes on PBMs as bipartisan support for wider reforms grows

3 years ago

MarketingRx roundup: Moderna, Pfizer, J&J top pharmas on innovation list; Bristol Myers taps IPG for media

3 years ago

Weight loss field expands as Pfizer's oral GLP-1 gathers comparisons to Novo's Wegovy in PhII data

3 years ago

Who else wanted to buy Iveric? Before the $5.9B Astellas deal, five biopharma companies took a look

3 years ago

Roche scraps second mid-stage schizophrenia trial in as many years

3 years ago

First page Previous page 124 125 126127128 129 130 Next page Last page